Literature DB >> 15599100

Combined effects of psychostimulants and morphine on locomotor activity in mice.

Tomohisa Mori1, Shinobu Ito, Minoru Narita, Tsutomu Suzuki, Toshiko Sawaguchi.   

Abstract

Simultaneous administration of psychostimulants and opioids is a major drug abuse problem worldwide. This combination appears to produce synergistic effects on behavior at low doses; however, there is little direct evidence that the combination is stronger than either drug alone. Therefore, we investigated interactions between psychostimulants and morphine on locomotor activity in mice. Low doses of cocaine (5.0 mg/kg) or methamphetamine (0.5 mg/kg) and morphine (10 mg/kg) enhance locomotor activity in a synergistic fashion. Effective doses of cocaine (20 mg/kg) and morphine (20 mg/kg) increased locomotion in an additive fashion. In contrast, combination of methamphetamine (1.0 and 2.0 mg/kg) and morphine (10 and 20 mg/kg) did not merely enhance their effects (or attenuated the peak effects of methamphetamine-induced hyperlocomotion). These results indicate that different mechanisms explain the interaction between morphine and methamphetamine or cocaine. It is well known that psychostimulants- and opioids-induced hyperlocomotion is mediated by the activation of the dopaminergic system, however, haloperidol (a dopamine receptor antagonist) and U50,488H (which attenuates dopamine release from nerve terminals) significantly increased the effects of methamphetamine and morphine on the locomotor activity. These results suggest that excess dopaminergic activation may be involved in the effects of methamphetamine and morphine on locomotor activity in mice.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15599100     DOI: 10.1254/jphs.fpj04039x

Source DB:  PubMed          Journal:  J Pharmacol Sci        ISSN: 1347-8613            Impact factor:   3.337


  11 in total

1.  Modification of morphine-induced hyperlocomotion and antinociception in mice by clorgyline, a monoamine oxidase-A inhibitor.

Authors:  Nobue Kitanaka; Junichi Kitanaka; Motohiko Takemura
Journal:  Neurochem Res       Date:  2006-06-23       Impact factor: 3.996

2.  Genetically correlated effects of selective breeding for high and low methamphetamine consumption.

Authors:  J M Wheeler; C Reed; S Burkhart-Kasch; N Li; C L Cunningham; A Janowsky; F H Franken; K M Wiren; J G Hashimoto; A C Scibelli; T J Phillips
Journal:  Genes Brain Behav       Date:  2009-07-21       Impact factor: 3.449

Review 3.  Cocaine and HIV-1 interplay: molecular mechanisms of action and addiction.

Authors:  Shilpa Buch; Honghong Yao; Minglei Guo; Tomohisa Mori; Tsung-Ping Su; John Wang
Journal:  J Neuroimmune Pharmacol       Date:  2011-07-16       Impact factor: 4.147

4.  Histamine-dependent behavioral response to methamphetamine in 12-month-old male mice.

Authors:  Summer F Acevedo; Jacob Raber
Journal:  Brain Res       Date:  2011-04-03       Impact factor: 3.252

5.  Powerful behavioral interactions between methamphetamine and morphine.

Authors:  Keith A Trujillo; Monique L Smith; Melissa M Guaderrama
Journal:  Pharmacol Biochem Behav       Date:  2011-04-22       Impact factor: 3.533

6.  Automated home-cage monitoring as a potential measure of sickness behaviors and pain-like behaviors in LPS-treated mice.

Authors:  Peththa Wadu Dasuni Wasana; Opa Vajragupta; Pornchai Rojsitthisak; Pasarapa Towiwat
Journal:  PLoS One       Date:  2021-08-27       Impact factor: 3.240

7.  Naloxone induces frequent jumping after chronic morphine and methamphetamine co-administration in rats.

Authors:  Gholamreza Kaka; Ramin Rahmanzade; Farzin Safee; Abbas Haghparast
Journal:  Basic Clin Neurosci       Date:  2014

8.  The role of nonmuscle myosin II in polydrug memories and memory reconsolidation.

Authors:  Sherri B Briggs; Madalyn Hafenbreidel; Erica J Young; Gavin Rumbaugh; Courtney A Miller
Journal:  Learn Mem       Date:  2018-08-16       Impact factor: 2.460

9.  Automated home-cage for the evaluation of innate non-reflexive pain behaviors in a mouse model of inflammatory pain.

Authors:  Peththa Wadu Dasuni Wasana; Opa Vajragupta; Pornchai Rojsitthisak; Pasarapa Towiwat
Journal:  Sci Rep       Date:  2021-06-10       Impact factor: 4.379

10.  Adrenergic Agonists Bind to Adrenergic-Receptor-Like Regions of the Mu Opioid Receptor, Enhancing Morphine and Methionine-Enkephalin Binding: A New Approach to "Biased Opioids"?

Authors:  Robert Root-Bernstein; Miah Turke; Udaya K Tiruttani Subhramanyam; Beth Churchill; Joerg Labahn
Journal:  Int J Mol Sci       Date:  2018-01-17       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.